[go: up one dir, main page]

PH12014501772A1 - Rapidly disintegrating tablet - Google Patents

Rapidly disintegrating tablet

Info

Publication number
PH12014501772A1
PH12014501772A1 PH12014501772A PH12014501772A PH12014501772A1 PH 12014501772 A1 PH12014501772 A1 PH 12014501772A1 PH 12014501772 A PH12014501772 A PH 12014501772A PH 12014501772 A PH12014501772 A PH 12014501772A PH 12014501772 A1 PH12014501772 A1 PH 12014501772A1
Authority
PH
Philippines
Prior art keywords
disintegrating tablet
carbon dioxide
rapidly disintegrating
drug
function
Prior art date
Application number
PH12014501772A
Other versions
PH12014501772B1 (en
Inventor
Ito Yoshitaka
Maeda Atsushi
Kashihara Sumie
Otake Katsuto
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PH12014501772A1 publication Critical patent/PH12014501772A1/en
Publication of PH12014501772B1 publication Critical patent/PH12014501772B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Provided are: a rapidly disintegrating tablet (in particular, an orally disintegrating tablet) containing drug-containing particles imparting a desired function based on the properties of the drug, which tablet still fully expresses the function even after a formulation step which might sometimes have an impact on the function thereof; and a method for producing the same. The rapidly disintegrating tablet is obtained by treating, with carbon dioxide in a super critical or subcritical state or with carbon dioxide liquid or gas, a drug and a material which is given the function of a binding agent by treatment with carbon dioxide in a super critical or subcritical state or with carbon dioxide liquid or gas.
PH12014501772A 2012-03-02 2014-08-06 Rapidly disintegrating tablet PH12014501772B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012046501 2012-03-02
JP2012239773 2012-10-31
PCT/JP2013/055634 WO2013129644A1 (en) 2012-03-02 2013-03-01 Rapidly disintegrating tablet

Publications (2)

Publication Number Publication Date
PH12014501772A1 true PH12014501772A1 (en) 2014-11-10
PH12014501772B1 PH12014501772B1 (en) 2018-11-14

Family

ID=49082831

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501772A PH12014501772B1 (en) 2012-03-02 2014-08-06 Rapidly disintegrating tablet

Country Status (6)

Country Link
JP (1) JP6098634B2 (en)
KR (1) KR102092423B1 (en)
CN (1) CN104168891B (en)
PH (1) PH12014501772B1 (en)
TW (1) TWI612975B (en)
WO (1) WO2013129644A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104602693A (en) * 2012-08-31 2015-05-06 安斯泰来制药株式会社 Orally administered medical composition
EP2848241A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of linagliptin
EP2848242A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating formulations of Linagliptin
CN105194677A (en) * 2014-06-23 2015-12-30 天津金耀集团有限公司 Lactose celecoxib medicine composition
CA3073195A1 (en) 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
WO2020213589A1 (en) * 2019-04-15 2020-10-22 三生医薬株式会社 Tablet and method for producing tablet
CN112979964B (en) * 2021-02-22 2022-05-31 烟台大学 High-toughness shellac and preparation method thereof
CN116687871A (en) * 2023-06-07 2023-09-05 江西众诚方源制药有限公司 Orally disintegrating tablet of non-steroidal anti-inflammatory drug with high drug load for animals and its preparation process

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT745382E (en) 1994-01-31 2004-04-30 Yamanouchi Pharma Co Ltd COMPRESSION-FORMED FORM WITH INTRA-ORAL SOLUBILITY AND PROCESS FOR ITS PRODUCTION
JPH1133084A (en) 1994-02-10 1999-02-09 Yamanouchi Pharmaceut Co Ltd Intraoral soluble type tablet and manufacture thereof
JP2919771B2 (en) 1995-04-17 1999-07-19 佐藤製薬株式会社 Method for producing fast-dissolving tablet and fast-dissolving tablet produced by the method
ES2268020T3 (en) 2001-05-10 2007-03-16 Astellas Pharma Inc. FAST DISGREGATION TABLES OF ORAL CAVITY AND PROCESS TO PRODUCE THE SAME.
MY147403A (en) * 2003-04-29 2012-11-30 Kowa Co Composition containing medicine extremely slightly solube in water and method for preparation thereof
DE602004027296D1 (en) * 2003-12-17 2010-07-01 Pantec Ag METHOD FOR THE PRODUCTION OF FAST RESOLVED TABLETS
JP2006076971A (en) 2004-09-13 2006-03-23 Basf Ag Orally disintegrating tablet
EP1839650A1 (en) 2004-12-28 2007-10-03 Eisai R&D Management Co., Ltd. Quick disintegration tablet and method of producing the same
KR101075556B1 (en) * 2008-11-21 2011-10-20 씨제이제일제당 (주) Orally fast-disintegrating tablets and processes for the preparation thereof

Also Published As

Publication number Publication date
TW201350141A (en) 2013-12-16
CN104168891B (en) 2016-05-11
PH12014501772B1 (en) 2018-11-14
JP6098634B2 (en) 2017-03-22
TWI612975B (en) 2018-02-01
CN104168891A (en) 2014-11-26
KR102092423B1 (en) 2020-03-23
JPWO2013129644A1 (en) 2015-07-30
WO2013129644A1 (en) 2013-09-06
KR20140130736A (en) 2014-11-11

Similar Documents

Publication Publication Date Title
PH12014501772A1 (en) Rapidly disintegrating tablet
WO2012106356A3 (en) Virus-like particles and methods of use
TN2015000050A1 (en) Methods of treating a tauopathy
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MY179194A (en) Process for preparing therapeutic nanoparticles
MX2017007128A (en) Hydraulic fracturing composition, method for making and use of same.
WO2012110835A3 (en) Prussian blue based nanoparticle as multimodal imaging contrast material
HK1204970A1 (en) Polymer-agent conjugates, particles, compositions, and related methods of use
WO2013002479A3 (en) Nanoemulsion composition and method for preparing same
NZ608380A (en) Pharmaceutical composition comprising deferasirox
WO2014064410A3 (en) Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
EP3147353A4 (en) Method for producing pancreatic blast cells and pancreatic disease treatment agent containing pancreatic blast cells
MX2017007054A (en) Compositions and methods of using modified release solabegron for lower urinary tract symptoms.
MX2022006770A (en) Bendamustine solid dispersions and continuous infusion.
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
WO2012126005A3 (en) Polymer hydrogels for in vivo applications and methods for using and preparing same
WO2010086838A3 (en) Non-ad5 adenoviral vectors and methods and uses related thereto
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
PH12018550008A1 (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
WO2013108041A3 (en) Process and method for the treatment of materials, materials thus obtained and uses of these materials
WO2012004691A3 (en) Pharmaceutical formulations of rasagiline
EA201691644A1 (en) BENDER CONTROL IN THE PROCESS OF PRODUCTION OF SHOCK STRENGTH POLYSTYRENE
MX2016007596A (en) Composition and method for treating subterranean formation.
EP4248978A3 (en) Method and compounds for inhibiting the mcm complex and their application in cancer treatment